Jeffrey Dvergsten

698 total citations
20 papers, 377 citations indexed

About

Jeffrey Dvergsten is a scholar working on Epidemiology, Immunology and Hematology. According to data from OpenAlex, Jeffrey Dvergsten has authored 20 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Immunology and 7 papers in Hematology. Recurrent topics in Jeffrey Dvergsten's work include Inflammatory Myopathies and Dermatomyositis (11 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Jeffrey Dvergsten is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (11 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Jeffrey Dvergsten collaborates with scholars based in United States, Canada and Qatar. Jeffrey Dvergsten's co-authors include Mark E. Rosenberg, J. Carlos Manivel, R Correa-Rotter, Ricardo Correa‐Rotter, Patricia Griffin, Amy P.N. Skubitz, David Chmielewski, John R. Silkensen, Keith M. Skubitz and Mark E. Rosenberg and has published in prestigious journals such as Journal of Clinical Investigation, Kidney International and Frontiers in Immunology.

In The Last Decade

Jeffrey Dvergsten

20 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey Dvergsten United States 11 160 152 117 74 53 20 377
Françoise Parmentier France 10 103 0.6× 45 0.3× 126 1.1× 38 0.5× 24 0.5× 16 482
Kyoko Wakamatsu Japan 10 74 0.5× 45 0.3× 93 0.8× 46 0.6× 28 0.5× 23 360
Olivia van Oostrom Netherlands 8 46 0.3× 161 1.1× 160 1.4× 81 1.1× 20 0.4× 8 414
Alejandro Ferrer United States 10 73 0.5× 38 0.3× 88 0.8× 94 1.3× 16 0.3× 27 365
Smadar Gertel Israel 10 50 0.3× 166 1.1× 72 0.6× 41 0.6× 173 3.3× 27 423
Tzu-Ting Hsu Australia 4 67 0.4× 68 0.4× 182 1.6× 27 0.4× 42 0.8× 4 468
Ken Takeshima Japan 14 168 1.1× 67 0.4× 56 0.5× 189 2.6× 113 2.1× 34 476
Magdalena Dryglewska Poland 12 37 0.2× 68 0.4× 63 0.5× 137 1.9× 144 2.7× 36 359
Hanna Zielińska Poland 12 109 0.7× 193 1.3× 152 1.3× 58 0.8× 6 0.1× 31 479
Peter Sang Uk Park United States 8 87 0.5× 84 0.6× 147 1.3× 18 0.2× 49 0.9× 21 329

Countries citing papers authored by Jeffrey Dvergsten

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Dvergsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Dvergsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Dvergsten more than expected).

Fields of papers citing papers by Jeffrey Dvergsten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Dvergsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Dvergsten. The network helps show where Jeffrey Dvergsten may publish in the future.

Co-authorship network of co-authors of Jeffrey Dvergsten

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Dvergsten. A scholar is included among the top collaborators of Jeffrey Dvergsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Dvergsten. Jeffrey Dvergsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prinz, Joseph A., et al.. (2024). Genetic changes from type I interferons and JAK inhibitors: clues to drivers of juvenile dermatomyositis. Lara D. Veeken. 63(SI2). SI240–SI248. 5 indexed citations
2.
Dvergsten, Jeffrey, et al.. (2023). Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment. Frontiers in Medicine. 10. 1155839–1155839. 6 indexed citations
3.
Osman, Alaa G. M., et al.. (2023). Effect of type I interferon on engineered pediatric skeletal muscle: a promising model for juvenile dermatomyositis. Lara D. Veeken. 63(1). 209–217. 10 indexed citations
4.
Wahezi, Dawn M., et al.. (2023). The impact of the COVID-19 pandemic on patients with juvenile idiopathic inflammatory myopathies. Pediatric Rheumatology. 21(1). 100–100. 2 indexed citations
5.
Dvergsten, Jeffrey, Simon Eng, Rae S. M. Yeung, et al.. (2022). Gene Expression Profiles of Treatment Response and Non‐Response in Children With Juvenile Dermatomyositis. ACR Open Rheumatology. 4(8). 671–681. 5 indexed citations
6.
Dvergsten, Jeffrey, Ann M. Reed, Lawrence R. Landerman, et al.. (2021). Metabolomics analysis identifies a lipidomic profile in treatment-naïve juvenile dermatomyositis patients vs healthy control subjects. Lara D. Veeken. 61(4). 1699–1708. 6 indexed citations
7.
Dvergsten, Jeffrey, et al.. (2020). Juvenile Dermatomyositis and Development of Malignancy: 2 Case Reports and a Literature Review. The Journal of Rheumatology. 47(3). 479–479. 5 indexed citations
8.
Liu, Kuan, George Tomlinson, Ann M. Reed, et al.. (2020). Pilot Study of the Juvenile Dermatomyositis Consensus Treatment Plans: A CARRA Registry Study. The Journal of Rheumatology. 48(1). 114–122. 13 indexed citations
9.
Reed, Ann M., Cynthia S. Crowson, & Jeffrey Dvergsten. (2019). A Path to Prediction of Outcomes in Juvenile Idiopathic Inflammatory Myopathy. Frontiers in Immunology. 10. 638–638. 3 indexed citations
10.
Crowson, Cynthia S., Richard S. Pendegraft, Michael Strausbauch, et al.. (2019). Interferon Chemokine Score and Other Cytokine Measures Track With Changes in Disease Activity in Patients With Juvenile and Adult Dermatomyositis. ACR Open Rheumatology. 1(2). 83–89. 11 indexed citations
11.
Ferguson, Ian, Patricia Griffin, Joshua J. Michel, et al.. (2018). T Cell Receptor-Independent, CD31/IL-17A-Driven Inflammatory Axis Shapes Synovitis in Juvenile Idiopathic Arthritis. Frontiers in Immunology. 9. 1802–1802. 17 indexed citations
12.
Kalampokis, Ioannis, Guglielmo M. Venturi, Jonathan C. Poe, et al.. (2016). The Regulatory B Cell Compartment Expands Transiently During Childhood and Is Contracted in Children With Autoimmunity. Arthritis & Rheumatology. 69(1). 225–238. 18 indexed citations
13.
14.
Dvergsten, Jeffrey & Ann M. Reed. (2014). Progress and prognosis in juvenile dermatomyositis. International Journal of Clinical Rheumatology. 9(6). 567–584. 1 indexed citations
15.
Dvergsten, Jeffrey, Patricia Griffin, Sameem Abedin, et al.. (2013). Premature Cell Senescence and T Cell Receptor–Independent Activation of CD8+ T Cells in Juvenile Idiopathic Arthritis. Arthritis & Rheumatism. 65(8). 2201–2210. 29 indexed citations
16.
Vallejo, Abbe N., David Hamel, Amanda Way, et al.. (2010). Expansions of NK-like αβT cells with chronologic aging: Novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells. Ageing Research Reviews. 10(3). 354–361. 29 indexed citations
17.
Silkensen, John R., Keith M. Skubitz, Amy P.N. Skubitz, et al.. (1995). Clusterin promotes the aggregation and adhesion of renal porcine epithelial cells.. Journal of Clinical Investigation. 96(6). 2646–2653. 66 indexed citations
18.
Dvergsten, Jeffrey, J. Carlos Manivel, R Correa-Rotter, & Mark E. Rosenberg. (1994). Expression of clusterin in human renal diseases. Kidney International. 45(3). 828–835. 68 indexed citations
19.
Nath, Karl A., Jeffrey Dvergsten, R Correa-Rotter, et al.. (1994). Induction of clusterin in acute and chronic oxidative renal disease in the rat and its dissociation from cell injury.. PubMed. 71(2). 209–18. 26 indexed citations
20.
Rosenberg, Mark E., Jeffrey Dvergsten, & Ricardo Correa‐Rotter. (1993). Clusterin: an enigmatic protein recruited by diverse stimuli.. PubMed. 121(2). 205–14. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Françoise Parmentier Breakdown of academic impact, for papers by Kyoko Wakamatsu Breakdown of academic impact, for papers by Olivia van Oostrom Breakdown of academic impact, for papers by Alejandro Ferrer Breakdown of academic impact, for papers by Smadar Gertel Breakdown of academic impact, for papers by Tzu-Ting Hsu Breakdown of academic impact, for papers by Ken Takeshima Breakdown of academic impact, for papers by Magdalena Dryglewska Breakdown of academic impact, for papers by Hanna Zielińska Breakdown of academic impact, for papers by Peter Sang Uk Park
Rankless by CCL
2026